CompletedPhase 1NCT00006098
PS-341 in Treating Patients With Hematologic Cancer
Studying Acute mast cell leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Principal Investigator
- Steven Soignet, MDMemorial Sloan Kettering Cancer Center
- Intervention
- bortezomib(drug)
- Eligibility
- 18 years · All sexes
- Timeline
- 2000 – 2001
Study locations (1)
- Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00006098 on ClinicalTrials.govOther trials for Acute mast cell leukemia
Additional recruiting or active studies for the same condition.